Fundraising FoxT. Rowe Price — 2018 Investments
4 investments dated 2018 · listed companies and verified rows first · show all
Outset Medical develops dialysis technology aimed at driving broader adoption and lowering the cost of care for patients and healthcare providers.
Enterprise SoftwareHardwareHealthtechMedical DevicesSan Jose, US
Nabeel Ahmed(Executive Officer)inMarc Nash(Executive Officer)inJohn Brottem(General Counsel)inLeslie Trigg(Chair and CEO)inJeff Mack(Executive Officer)inRenee Gaeta(Chief Financial Officer)in
Co-investorsThe Vertical GroupDurable Capital PartnersFidelity InvestmentsWarburg Pincus
PagerDuty provides a platform for incident response and operations management that enables teams across technical and business functions to respond to critical events in real time.
AI & Machine LearningCloud ComputingDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US
Alex Solomon(CTO)inDan Alexandru Solomon(Director)Jennifer Tejada(Executive Chair)inSteven Gatoff(Executive Officer)inJohn DiLullo(Chief Executive Officer)inBaskar Puvanathasan(Software Engineer / Product Manager)
Co-investorsAccelAndreessen HorowitzAurumBaseline VenturesBessemer Venture PartnersBling Capital+17 more
Checkr provides background verification and fraud detection services for hiring, loan approvals, insurance, and tenant screening decisions.
AI & Machine LearningEnterprise SoftwareHR TechSaaSSan Francisco, US
Daniel Yanisse(CEO)inJonathan Perichon(Founder)inNaeem Ishaq(Executive Officer)inJennifer Yeh(Executive Officer)inTodd Freedman(Executive Officer)inChris Hollindale(Head of Checkr Pay)in
Co-investorsAccelActivant CapitalBond Capital ManagementCoatue ManagementDCVC (Data Collective)Earl Grey Capital+22 more
San Francisco, US
Mariam Naficy(Founder)inBrady Wood(Executive Officer)Melissa Kim(Executive Officer)inMateo Bryant(Executive Officer)inSarah Wallis(Executive Officer)inSpencer Lee(Executive Officer)
Co-investorsNorwest Venture PartnersThe Perkins FundBenchmarkMenlo VenturesPermiraRidge Ventures+2 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.